Spruce Biosciences (SPRB) Non Operating Interest Expenses (2019 - 2026)
Spruce Biosciences (SPRB) reported Non Operating Interest Expenses of $1.1 million for Q2 2026, compared with $29,000 a year earlier and up 62.8% from the prior quarter.
Powered by 
Analysis
Spruce Biosciences (SPRB) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Spruce Biosciences' Non Operating Interest Expenses came in at $1.8 million, up 835.4% year-over-year; for FY2025, it came in at $90,000, down 70.7% from FY2024.
- Non Operating Interest Expenses has a five-year compound annual growth rate of -22.6% (FY2020 to FY2025).
- By year, Non Operating Interest Expenses came in at $307,000 in FY2024 (-36.4%), $483,000 in FY2023 (+15.0%), $420,000 in FY2022 (+21.7%) and $345,000 in FY2021 (+6.8%).
- The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to Q3 2019.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q1 2023 (growth of 50.6%); the low point was Q4 2025 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $674,000 (Q1 2026), $6,000 (Q4 2025) and $19,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Spruce Biosciences | 133.73 Mn | 133.73 Mn | - | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 674,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 83,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 129,000.00 |
| Sep 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 88,000.00 |
API Access
Spruce Biosciences Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SPRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SPRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SPRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();